Precision BioSciences (DTIL) Tops Q1 EPS by 9c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of ($0.46), $0.09 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $3.32 million versus the consensus estimate of $6.63 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Raymond James Starts Tonix Pharma (TNXP) at Strong Buy
• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c